{"protocolSection":{"identificationModule":{"nctId":"NCT00754429","orgStudyIdInfo":{"id":"2008_025"},"secondaryIdInfos":[{"id":"MK0954-338"}],"organization":{"fullName":"Taipei Veterans General Hospital, Taiwan","class":"OTHER_GOV"},"briefTitle":"The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)","officialTitle":"The Effect of Losartan Versus Amlodipine-based Antihypertensive Therapy on Atherosclerotic Inflammatory Markers and Cerebrovascular Regulation in Ischemic Stroke Patients"},"statusModule":{"statusVerifiedDate":"2013-10","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2004-06"},"primaryCompletionDateStruct":{"date":"2009-06","type":"ACTUAL"},"completionDateStruct":{"date":"2009-07","type":"ACTUAL"},"studyFirstSubmitDate":"2008-09-16","studyFirstSubmitQcDate":"2008-09-17","studyFirstPostDateStruct":{"date":"2008-09-18","type":"ESTIMATED"},"lastUpdateSubmitDate":"2013-10-22","lastUpdatePostDateStruct":{"date":"2013-10-23","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"oldNameTitle":"Executive Vice President, Clinical and Quantitative Sciences","oldOrganization":"Merck & Co., Inc."},"leadSponsor":{"name":"Taipei Veterans General Hospital, Taiwan","class":"OTHER_GOV"}},"descriptionModule":{"briefSummary":"To compare the effect of losartan vs amlodipine-based antihypertensive therapy on atherosclerotic inflammatory markers and cerebrovascular regulation in Ischemic stroke patients."},"conditionsModule":{"conditions":["Ischemic Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":40,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"A","type":"EXPERIMENTAL","description":"Losartan 50mg qd for 30 weeks, if blood pressure \\> 140/90, or mean arterial Bp ≧ 15% of baseline, then add on diuretics.","interventionNames":["Drug: losartan"]},{"label":"B","type":"ACTIVE_COMPARATOR","description":"Amlodipine 5 mg q.d for 30 weeks, if blood pressure \\> 140/90, or mean arterial Bp ≧ 15% of baseline, then add on diuretics.","interventionNames":["Drug: amlodipine"]}],"interventions":[{"type":"DRUG","name":"losartan","description":"losartan 50mg qd for 30 weeks.","armGroupLabels":["A"],"otherNames":["losartan potassium","COZAAR®","MK0954"]},{"type":"DRUG","name":"amlodipine","description":"amlodipine 5 mg q.d for 30 weeks.","armGroupLabels":["B"],"otherNames":["Norvasc"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"MCAFV and TCD for measuring cerebral autoregulatory indices at week 0, week 6, week 18 and week 30.","timeFrame":"At week 0, week 6, week 18 and week 30."}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient With Tia Or Ischemic Stroke (Event Has Occurred More Thaan 4 Weeks But Less Than 24 Weeks, And Modified Rankin'S Scale, Mrs\\<=3) With Mild To Moderate Hypertension\n* Patient Has No Other Active Medical Problem, Which Might Of Itself Or By This Treatment Significantly Affect The Patient's Blood Pressure\n* The Blood Level Of Hscrp\\>0.2 Ng/Dl By Two Measurements Performed Respectively One-Week Apart\n\nExclusion Criteria:\n\n* Patients With Cardiac Arrhythmia\n* Diabetes Mellitus\n* Patient With Other Active Inflammatory Diseases Such As Rheumatoid Disease, Fever And Systemic Infection Which Will Confound The Level Of Serum CRP\n* Patients With Known Intolerance, Contraindication Or Hypersensitivity To Losartan, Amlodipine and Hydrochlorothiazide\n* Patient With Myocardial Infarction Within The Recent Three Months\n* Anatomy Abnormality Which Results In Poor Bilateral Temporal Acoustic Windows Which Prevent TCD Procedure\n* Patient Who Requires Continuous Medication With Alpha Blocking Agents\n* Concurrent Usage Of Acei\n* Poor Mental Function Or Any Other Reason To Expect Difficulty In Meeting The Requirements Of The Study\n* Concurrent Treatment With Other Lipid-Lowering Drug\n* Childbearing Potential Women Not Undergoing Adequate Contraceptive Control","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Medical Monitor","affiliation":"Merck Sharp & Dohme LLC","role":"STUDY_DIRECTOR"}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14","removedCountries":["Taiwan"]},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000019808","term":"Losartan"},{"id":"D000017311","term":"Amlodipine"}],"ancestors":[{"id":"D000000959","term":"Antihypertensive Agents"},{"id":"D000002121","term":"Calcium Channel Blockers"},{"id":"D000049990","term":"Membrane Transport Modulators"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000077264","term":"Calcium-Regulating Hormones and Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000014665","term":"Vasodilator Agents"},{"id":"D000000889","term":"Anti-Arrhythmia Agents"},{"id":"D000047228","term":"Angiotensin II Type 1 Receptor Blockers"},{"id":"D000057911","term":"Angiotensin Receptor Antagonists"}],"browseLeaves":[{"id":"M19290","name":"Amlodipine","asFound":"Step","relevance":"HIGH"},{"id":"M3967","name":"Antihypertensive Agents","relevance":"LOW"},{"id":"M7101","name":"Diuretics","relevance":"LOW"},{"id":"M21391","name":"Losartan","asFound":"800","relevance":"HIGH"},{"id":"M5071","name":"Calcium","relevance":"LOW"},{"id":"M5088","name":"Calcium, Dietary","relevance":"LOW"},{"id":"M5074","name":"Calcium Channel Blockers","relevance":"LOW"},{"id":"M9479","name":"Hormones","relevance":"LOW"},{"id":"M17102","name":"Vasodilator Agents","relevance":"LOW"},{"id":"M3903","name":"Anti-Arrhythmia Agents","relevance":"LOW"},{"id":"M3822","name":"Angiotensin II","relevance":"LOW"},{"id":"M289298","name":"Giapreza","relevance":"LOW"},{"id":"M3825","name":"Angiotensinogen","relevance":"LOW"},{"id":"M25479","name":"Angiotensin II Type 1 Receptor Blockers","relevance":"LOW"},{"id":"M28606","name":"Angiotensin Receptor Antagonists","relevance":"LOW"}],"browseBranches":[{"abbrev":"AnAg","name":"Antihypertensive Agents"},{"abbrev":"ChanBlk","name":"Channel Blockers"},{"abbrev":"VaDiAg","name":"Vasodilator Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"AnArAg","name":"Anti-Arrhythmia Agents"},{"abbrev":"BDCA","name":"Bone Density Conservation Agents"},{"abbrev":"VaCoAg","name":"Vasoconstrictor Agents"}]}},"hasResults":false}